2005 Release: HapMap Background: International Project Participants

National Human Genome Research Institute

National Institutes of Health
U.S. Department of Health and Human Services


International HapMap Project Participants

October 2005

Country Research Group Funding Agency Role Percent Genome in Phase I
Japan Yusuke Nakamura
RIKEN and
University of Tokyo
Japanese Ministry of Education, Culture, Sports, Science and Technology Genotyping- Third Wave 24.3 %
Ichiro Matsuda
Health Sciences
University of Hokkaldo with Eubios Ethics Institute
and Shinshu University
Japanese Ministry of Education, Culture, Sports, Science and Technology Public Consultation and Sample Collection
United Kingdom David Bentley
Wellcome Trust Sanger Institute
Wellcome Trust Genotyping- Illumina BeadArray 23.7%
Peter Donnelly
University of Oxford
Wellcome Trust,
Nuffield Foundation,
Wolfson Foundation,
The SNP Consortium,
National Institutes of Health (NIH)
Analysis
Lon Cardon
University of Oxford
Wellcome Trust Centre
for Human Genetics
Wellcome Trust, The SNP Consortium, NIH Analysis
Canada Thomas Hudson
McGill University and Génome Québec
Innovation Centre
Genome Canada, Génome Québec Genotyping-Illumina BeadArray 10.1%
China (The Chinese HapMap Consortium Huanming Yang
Beijing Genomics Institute
Changqing Zeng
Beijing Genomics Institute
Yan Shen
Chinese National Human
Genome Center at Beijing
Chinese Ministry of Science and Technology, Chinese Academy of Sciences, National Natural Science Foundation of China Genotyping-Sequenom MassExtend, Illumina BeadArray 5.9%
Wei Huang
Chinese National Human
Genome Center at Shanghai
Chinese Ministry of Science and Technology, Chinese Academy of Sciences, National Natural Science Foundation of China Genotyping-Illumina BeadArray 1.1%
Lap-Chee Tsui
Hong Kong
HapMap Group

Paul Kwong-Hang Tam
The University of
Hong Kong

William Wai-Nam Mak
The University of
Hong Kong
Jeffrey Tze-Fei Wong
Hong Kong University of Science and Technology
Mary Miu Yee Waye
The Chinese University of Hong Kong
Hong Kong Innovation and Technology Commission, University Grants Committee of Hong Kong Genotyping-Sequenom Mass Extend 2.5%
Houcan Zhang
Beijing Normal University
Chinese Ministry of
Science and Technology
Community Engagement
Changqing Zeng
Beijing Genomics Institute
Chinese Ministry of
Science and Technology
Sample Collection
United States Mark Chee
Illumina
National Institutes of Health (NIH) Genotyping-Illumina BeadArray 16.1%
David Altshuler
Broad Institute of Harvard and MIT
NIH Genotyping-Sequenom MassExtend, Illumina BeadArray

Analysis
9.7%
Richard GIbbs
Baylor College of Medicine with ParAllele BioScience
NIH Genotyping-ParAllele 4.6%
Pul-Yan Kwok
University of California, San Francisco with Washington University in St. Louis
NIH Genotyping-Perkin Elmer AcycloPrim-FP 2.0%
Aravinda Chakravarti
Johns Hopkins School of Medicine
NIH Analysis
Gonšalo Abecasis
University of Michigan
NIH Analysis
Mark Leppert
University of Utah
W.M. Keck Foundation, Delores Dore Eccles Foundation, NIH Community Engagment and Sample Collection
Kelly Frazer
Perlegen Sciences
Wellcome Trust, Genome Canada, Génome Québec, Bristol-Myers Squibb Co., Pfizer Inc., The SNP Consortium, NIH Genotyping-High Density Oligonucleotide Array 2.6 million SNPs in Phase II
Nigeria Charles Rotimi
Howard University with University of Ibadan
NIH Community Engagement and Sample Collection
Data Coordination Lincoln Stein
Cold Spring Harbor Laboratory
The SNP Consortium, NIH Data Coordination Center


Top of page

Last Reviewed: January 2007